Oncology News and Research

RSS
Illumina introduces fast, highly accurate Veriseq NIPT Solution in the European Union

Illumina introduces fast, highly accurate Veriseq NIPT Solution in the European Union

Researchers uncover critical pathway that helps pancreatic cancer cells turn off immune system

Researchers uncover critical pathway that helps pancreatic cancer cells turn off immune system

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

MSU and Venn Therapeutics develop promising therapy to delay B16 melanoma tumor growth

MSU and Venn Therapeutics develop promising therapy to delay B16 melanoma tumor growth

Protein testing may become potential tool to detect prostate cancer

Protein testing may become potential tool to detect prostate cancer

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

Researchers discover potential novel strategy for improving immunotherapy against cancer

Researchers discover potential novel strategy for improving immunotherapy against cancer

Essen BioScience Launches the IncuCyte® S3 Live-Cell Analysis Platform

Essen BioScience Launches the IncuCyte® S3 Live-Cell Analysis Platform

New gene-based blood tests can reliably detect previously unidentifiable forms of skin cancer

New gene-based blood tests can reliably detect previously unidentifiable forms of skin cancer

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Feinstein Institute professor develops new tool to evaluate quality of eHealth applications

Feinstein Institute professor develops new tool to evaluate quality of eHealth applications

ANGLE’s Parsortix system could help predict metastasis in prostate cancer

ANGLE’s Parsortix system could help predict metastasis in prostate cancer

Clinical research trial investigates new treatment approach for early-stage eye melanoma

Clinical research trial investigates new treatment approach for early-stage eye melanoma

New analysis shows correlation between testosterone-lowering therapy for prostate cancer and dementia

New analysis shows correlation between testosterone-lowering therapy for prostate cancer and dementia

Scientists uncover how tumor cells can switch disguises to spread easily around the body

Scientists uncover how tumor cells can switch disguises to spread easily around the body

Study: Colorectal cancer patients with certain genetic mutations may benefit more from aspirin

Study: Colorectal cancer patients with certain genetic mutations may benefit more from aspirin

Study explores new immunotherapy combinations to treat prostate cancer

Study explores new immunotherapy combinations to treat prostate cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.